ECG vs BTSG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

ECG

60.6
AI Score
VS
ECG Wins

BTSG

53.8
AI Score

Investment Advisor Scores

ECG

61score
Recommendation
BUY

BTSG

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ECG BTSG Winner
Revenue 2.27B 7.49B BTSG
Net Income 142.21M 233.06M BTSG
Gross Margin 13.8% 13.0% ECG
Net Margin 6.3% 3.1% ECG
Operating Income 189.46M 251.84M BTSG
ROE 18.4% 11.4% ECG
ROA 6.9% 3.9% ECG
Total Assets 2.06B 5.99B BTSG
Debt/Equity 0.36 1.07 ECG
Current Ratio 1.59 1.59 BTSG

Relative Price Performance (Last 90 Days)

ECG 1M: -14.7% · 3M: -16.9% BTSG 1M: -1.6% · 3M: -6.9%

Current Technical Phase

ECG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.4 · Price: $119.42

BTSG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $58.73

Fundamentals Snapshot

Metric ECG BTSG
Market Cap
Forward P/E 19.9 25.8
Trailing P/E 23.5 51.7
Revenue (TTM)
Revenue Growth 0.3% 0.2%
Gross Margin 0.1% 0.1%
Operating Margin 0.1% 0.0%
EPS 4.90 1.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.